2024 annual financial data
Cue Biopharma 2024 Operating margin
Cue Biopharma 2024 operating margin with verified reported values.
Direct answer
Operating margin was -446.86%.
Operating income was -41,500,000 USD and net income was -40,674,000 USD.
Operating cash flow was -36,329,000 USD.
Get free Cue Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,287,000 USD
- Operating income
- -41,500,000 USD
- Net income
- -40,674,000 USD
- Operating cash flow
- -36,329,000 USD